HOME >> BIOLOGY >> NEWS
Vaccinating wildlife can reduce human risk for Lyme disease

Direct field evidence shows that Lyme disease in humans can be prevented by vaccinating wildlife, researchers in the Department of Epidemiology and Public Health at Yale School of Medicine report in the Proceedings of the National Academy of Sciences.

In a four-year study of isolated woodlands near New Haven, nearly 1,000 white-footed mice were trapped and either vaccinated against Lyme disease or given a placebo. Fewer deer ticks tested positive for Lyme disease in the experimental plots where mice had been vaccinated. Fewer ticks carrying infection reduced the risk for humans getting Lyme disease from a tick bite.

"Vaccinating wildlife increases our prevention options," said principal investigator Durland Fish, professor of epidemiology at Yale, who led the study with Jean Tsao, now at Michigan State University and microbiologist Alan Barbour at University of California at Irvine. "Despite a record increase in cases, efforts to prevent Lyme disease with a human vaccine were set back in 2002 when it was pulled from the market due to poor sales."

Although the study showed significant reduction in risk and was the first demonstration of a wildlife vaccination effect for any vector-borne disease, the reduction was not as great as the investigators had hoped.

A surprising result was that mice are not as important in maintaining the Lyme disease bacterium in nature as previous studies showed. "If only mice were responsible for infecting the ticks, we would have seen a much greater reduction," Fish explained. "We now believe that mice are responsible for only 27 to 55 percent of the infection found in ticks. This changes our view on how Lyme disease is circulated between wildlife and ticks."

Fish said that in addition to mice, other animals must receive Lyme disease vaccination in order to further reduce risk to humans. Oral vaccines, similar
'"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
13-Dec-2004


Page: 1 2

Related biology news :

1. The new wildlife refuge -- Golf courses?
2. Manipulating nature: Scientists query wildlife birth-control method
3. Study questions the biodiversity hotspot approach to wildlife conservation
4. Research highlights how farmers agri-environment schemes could do more for wildlife
5. High-tech equipment may help reduce wildlife-vehicle collisions
6. Moving wildlife detrimental to oral rabies vaccination project
7. UGA researchers find that hunting can increase the severity of wildlife disease epidemics
8. Report: Canadas Yellowstone too small for wildlife
9. Afghanistan to protect wildlife and wild lands
10. Test for dioxin sensitivity in wildlife could result from new study
11. Monkey-dung study offers clues about land-use, wildlife ecology

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Vaccinating wildlife can reduce human risk for Lyme disease

(Date:12/11/2014)... 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of ... report to their offering. One ... adoption of multimodal biometric systems. Multimodal biometric systems ... for verification and identification purposes. This helps to ...
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical Center ... for its School of Medicine. Funding for this $50 ... campaign that will be publicly launched next summer. ... in the former 60 series R.J. Reynolds Tobacco Company ... Construction will begin immediately with plans to be ready ...
(Date:12/5/2014)... , Dec. 4, 2014  Tute Genomics, a ... $2.3 million in Series A1 funding led by UK-based ... also participated in the investment round. "We ... healthcare community adopts next-generation sequencing and seeks new approaches ... Reid Robison , MD MBA, and CEO of ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
Cached News: